Jan Astermark

141 – 150 of 191

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/af7e247a-381e-4a1c-a1d8-7625b1488a9e?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
14
15
16
17
…
20
next »

2007
Mark Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors.
Astermark, Jan ^LU ; Rocino, A ; Von Depka, M ; van den Berg, H M ; Gringeri, A ; Mantovani, L G ; Morado, M ; Garrido, R P ; Schiavoni, M and Villar, A , et al. (2007) In Haemophilia 13(1). p.38-45
- Contribution to journal › Article
Mark Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following Myelodysplastic syndrome
Grovdal, Michael ; Khan, Rasheed ; Aggerholm, Anni ; Antunovic, Petar ; Astermark, Jan ^LU ; Bernell, Per ; Engstroem, Lena-Varia ; Kjeldsen, Lars ; Linder, Olle and Nilsson, Lars ^LU , et al. (2007) In Clinical Cancer Research 13(23). p.7107-7112
- Contribution to journal › Article
Mark A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor.
Astermark, Jan ^LU ; Donfield, Sharyne M ; Dimichele, Donna M ; Gringeri, Alessandro ; Gilbert, Steven A ; Waters, Jennifer and Berntorp, Erik ^LU (2007) In Blood 109(Sep 21). p.546-551
- Contribution to journal › Article
Mark The APC-PCI complex concentration predicts outcome of aortic surgery.
Nilsson, Gunnar ^LU ; Strandberg, Karin ^LU ; Astermark, Jan ^LU ; Vernersson, Einar ^LU ; Stenflo, Johan ^LU and Berntorp, Erik ^LU (2007) In Thrombosis Research 120. p.237-244
- Contribution to journal › Article
2006
Mark Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.
Astermark, Jan ^LU ; Morado, M ; Rocino, A ; van den Berg, H M ; von Depka, M ; Gringeri, A ; Mantovani, L ; Garrido, R P ; Schiavoni, M and Villar, A , et al. (2006) In Haemophilia 12(4). p.363-371
- Contribution to journal › Article
Mark Inhibitor treatment in haemophilas A and B: Summary statement for the 2006 International Consensus Conference
Berntorp, Erik ^LU ; Shapiro, A ; Astermark, Jan ^LU ; Blanchette, V. S ; Collins, P. W ; Dimichele, D ; Escuriola, C ; Hay, C. R. M ; Hoots, W. K and Leissinger, C. A , et al. (2006) In Haemophilia 12. p.41281-41281
- Contribution to journal › Debate/Note/Editorial
Mark Basic aspects of inhibitors to factors VIII and IX and the influence of non-genetic risk factors.
Astermark, Jan ^LU (2006) In Haemophilia 12 Suppl 6. p.41499-41499
- Contribution to journal › Article
Mark Inhibitor development in hemophiliacs: The roles of genetic versus environmental factors
Lee, Christine A. ; Lillicrap, David and Astermark, Jan ^LU (2006) In Seminars in Thrombosis and Hemostasis 32. p.41561-41561
- Contribution to journal › Article
Mark Overview of inhibitors
Astermark, Jan ^LU (2006) 2004 World Federation of Hemophilia Congress 43(2, Suppl. S4). p.3-7
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
Mark Overview of inhibitors.
Astermark, Jan ^LU (2006) In Seminars in Hematology 43(2 Suppl 4). p.3-7
- Contribution to journal › Article

« previous
1
…
14
15
16
17
…
20
next »